Neubase therapeutics, inc. (OHRP)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Jun'10
REVENUES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

COST OF SALES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

GROSS PROFIT

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

0

0

0

0

0

OPERATING EXPENSES
General and administrative

12,052

11,228

9,095

3,923

3,869

2,546

3,634

3,659

4,229

5,041

5,278

6,361

6,622

8,184

7,656

7,656

7,546

7,915

7,509

7,807

7,038

5,041

4,287

3,715

3,068

1,763

1,775

279

171

172

135

132

120

108

104

410

0

0

0

Professional fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

957

771

858

875

518

460

362

338

0

0

0

-

Research and development

7,079

5,496

4,273

197

167

1,936

4,319

8,490

10,671

14,863

17,406

17,861

21,265

19,315

16,460

13,056

8,915

8,047

8,777

8,734

8,390

5,822

4,369

4,438

3,701

3,527

2,753

2,013

1,950

1,868

1,625

1,158

926

639

521

418

0

0

0

Research and development expense- license acquired

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,117

197

372

-417

1,812

-534

-3,545

-3,052

-3,977

-2,804

0

0

0

Change in fair value of contingent consideration

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,185

1,842

1,716

-763

-2,637

0

0

0

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on Impairment of intangible asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on settlement of liabilities

-

-

-

-

-

-

-

-

0

-

-

0

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of Intangibles

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Salaries and wages

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

814

471

704

649

605

575

279

279

0

0

0

-

TOTAL OPERATING EXPENSES

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

4,065

3,364

3,603

3,286

2,415

2,081

1,390

1,243

1,222

0

0

0

LOSS FROM OPERATIONS

-31,052

-28,644

-26,336

-10,929

-10,958

-11,195

-13,903

-12,791

-15,480

-20,986

-23,780

-25,330

-29,073

-27,979

-24,596

-21,527

-17,263

-17,473

-17,805

-17,143

-15,863

-11,025

-9,122

-7,847

-7,127

-5,827

-4,620

-4,065

-3,364

-3,603

-3,286

-2,415

-2,081

-1,390

-1,243

-1,222

0

0

0

OTHER INCOME (EXPENSE)
Depreciation and amortization

-

-

-

778

-

-

1,124

1,128

1,138

1,152

1,165

1,178

1,185

1,189

1,189

1,185

1,172

1,171

1,179

1,000

739

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on impairment of goodwill

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest expense

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

4

4

4

4

2

2

1

0

0

0

2

4

0

0

0

Change in fair value of warrant liabilities

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on disposal of fixed asset

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Equity in losses on equity method investment

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-103

-108

-78

-37

-10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expenses

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Royalty income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

70

70

70

0

0

0

Gain on settlement of debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

21

70

70

70

49

0

0

0

-

Total other expense, net

0

0

-

-

0

0

-

0

0

-

-

0

-

0

3

10

10

10

42

43

0

0

-

0

-

-

90

90

90

0

0

0

0

0

1

41

0

0

0

Interest income (expense), net

-

-

-

0

-

-

-

0

-

0

-

0

0

-

12

6

1

-5

-5

-8

-6

-5

-5

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Total Other Income

-

-

-

37

-

-

667

665

-0

0

-30

128

72

1,383

-1,170

-1,455

-1,365

728

2,607

2,708

2,723

-681

-7

3

-4

371

-1,031

283

460

-419

1,831

-465

-3,475

-2,911

-3,858

-2,697

0

0

0

LOSS FROM OPERATIONS BEFORE INCOME TAXES

-

-

-

-

-

-

-

-

-

0

-

-

-29,001

-26,596

-25,766

-22,983

-18,629

-16,744

-15,197

-14,434

-13,139

-11,707

-9,130

-7,844

-7,132

-5,456

-5,652

-3,781

-2,903

-4,023

-1,454

-2,880

-5,557

-4,302

-5,101

-3,919

0

0

0

INCOME TAXES

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

0

-

0

0

0

0

0

0

0

0

LOSS BEFORE DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-2,880

-5,557

-4,302

-5,101

-3,919

0

0

0

Income from discontinued operations(including gain on disposal of $606,000)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

Income tax benefit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

GAIN ON DISCONTINUED OPERATIONS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

0

0

0

0

0

NET LOSS

-32,323

-29,975

-26,958

-11,007

-10,419

-10,574

-13,236

-12,125

-15,481

-20,986

-23,810

-25,202

-29,001

-26,596

-25,766

-22,983

-18,629

-16,744

-15,197

-14,434

-13,139

-11,707

-9,130

-7,844

-7,132

-5,456

-5,652

-3,781

-2,903

-4,023

-1,454

-2,880

-5,557

-4,302

-5,101

-3,919

0

0

0

Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.02

-

-

-0.03

-0.03

0.01

-

-0.08

0.00

-

-

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

0.00

0.00

0.00

-

0.00

0.00

-

-

BASIC AND DILUTED LOSS PER SHARE (in dollars per share)

-0.26

-0.26

-2.28

-0.40

-0.33

-0.25

2.21

-0.19

-0.77

-1.48

0.00

-0.07

-0.21

-0.21

-0.21

-0.24

-0.17

-0.20

-0.13

-0.11

-0.12

-0.18

-0.12

-0.09

-0.10

-0.10

-0.07

-0.07

-0.02

-0.14

-0.05

-0.03

-0.03

0.01

-

-0.08

0.00

-

-

WEIGHTED AVERAGE SHARES OUTSTANDING:
BASIC AND DILUTED

17,075

17,071

18,319

2,829

6,074

5,863

217,142

2,823

2,823

2,810

55,521

53,986

36,738

32,836

32,078

31,501

31,344

30,472

30,321

30,323

27,713

25,259

24,969

23,486

20,237

19,872

24,330

18,707

15,935

15,857

-

14,011

41,620

-

-

39,702

39,702

-

35,379

Continuing operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.00

Discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

0.00

[EarningsPerShareBasic]

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.01

0.00

Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

40,041

-

-

-

35,593

-

Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

53,142

-

-

-

0

-